Development of an Urticaria Control Test
Completed
- Conditions
- Chronic Urticaria
- Registration Number
- NCT01610128
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
The aim of the project is to develop a patient reported outcome instrument to assess disease control in chronic urticaria patients (Urticaria Control Test - UCT) of age 12 and older.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 508
Inclusion Criteria
all patients suffering from chronic forms of urticaria are eligible
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie chronic urticaria symptom control as assessed by the Urticaria Control Test (NCT01610128)?
How does the Urticaria Control Test compare to standard-of-care assessments for chronic urticaria disease activity?
Are specific biomarkers associated with chronic urticaria patient response to disease control interventions identified in NCT01610128?
What adverse events are reported in patient-reported outcome instruments for chronic urticaria management?
What combination therapies or alternative approaches show promise for chronic urticaria patient-reported control metrics?
Trial Locations
- Locations (2)
Universitätshautklinik Mainz
🇩🇪Mainz, Rheinland-Pfalz, Germany
Allergie-Centrum-Charite
🇩🇪Berlin, Germany
Universitätshautklinik Mainz🇩🇪Mainz, Rheinland-Pfalz, Germany